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BACKGROUND: Metabolic disorders are commonly investigated using knockout and transgenic mouse models on the C57BL/6N genetic
background due to its genetic susceptibility to the deleterious metabolic effects of high-fat diet (HFD). There is growing awareness
of the need to consider sex in disease progression, but limited attention has been paid to sexual dimorphism in mouse models and
its impact in metabolic phenotypes. We assessed the effect of HFD and the impact of sex on metabolic variables in this strain.
METHODS: We generated a reference data set encompassing glucose tolerance, body composition and plasma chemistry data
from 586 C57BL/6N mice fed a standard chow and 733 fed a HFD collected as part of a high-throughput phenotyping pipeline.
Linear mixed model regression analysis was used in a dual analysis to assess the effect of HFD as an absolute change in phenotype,
but also as a relative change accounting for the potential confounding effect of body weight.
RESULTS: HFD had a significant impact on all variables tested with an average absolute effect size of 29%. For the majority of
variables (78%), the treatment effect was modified by sex and this was dominated by male-specific or a male stronger effect. On
average, there was a 13.2% difference in the effect size between the male and female mice for sexually dimorphic variables. HFD
led to a significant body weight phenotype (24% increase), which acts as a confounding effect on the other analysed variables. For
79% of the variables, body weight was found to be a significant source of variation, but even after accounting for this confounding
effect, similar HFD-induced phenotypic changes were found to when not accounting for weight.
CONCLUSION: HFD and sex are powerful modifiers of metabolic parameters in C57BL/6N mice. We also demonstrate the value of
considering body size as a covariate to obtain a richer understanding of metabolic phenotypes.
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INTRODUCTION
The development of transgenic and knockout mouse technologies
has facilitated the production of in vivo models that have greatly
enhanced our understanding of disease mechanisms and have
become commonplace in medical research. The C57BL/6N (B6N)
background strain is becoming the standard background for
genetic manipulation of the mouse genome.1,2 Similar to the well-
known C57BL/6J strain, B6N mice are susceptible to high-fat diet
(HFD)-induced conditions including body weight gain, increased
adipose mass, liver lipid infiltration and alterations in biochemical
variables.1,3 Because of the increasing adoption of this background
for genetically modified and non-genetically modified studies in
mice, baseline data from C57BL/6N mice are important for being
able to examine its performance between laboratories and to justify
the use of this strain when designing experimental procedures.
Historically, research into biological processes has overlooked
the impact of sex. Systematic reviews of animal research studies
identified a vast over-representation of male mice, and where
both sexes were studied, two-thirds of the time, the results were
not statistically analysed with regard to the effect of sex.4–6 The
observations that many human diseases exhibit some sex
differences in prevalence,7 course, severity8 and drug reaction9
has led to a growing concern over the sex imbalance and lack of
generalisability of results in biomedical research.10 Sexual dimorph-
ism can be defined as the difference in a particular characteristic
between sexes in either standard conditions, or in response to a
stimulus. Assessment of sexual dimorphism under standard or non-
challenged conditions can be thought of as binary (for example, the
change in sex leads to the feature being present or absent; or if
continuous trait larger or smaller). In contrast, assessing sexually
dimorphic responses to stimuli is more complex with multiple
potential outcomes: both sexes show similar responses; only one
sex is affected by the stimulus; both sexes are affected to differing
degrees; and sexes have opposite responses to a stimulus. Despite
being a well-known phenomenon, to date, we have only identified
a few publications that explicitly looked at the role of sex in the
response to HFD in mice.11–14
Typically with metabolic studies, the treatment will be
associated with a weight change. However, body weight is known
to be a powerful co-variable and this correlation can lead to an
association that is true but potentially biologically misleading. The
importance of considering weight in interpreting phenotypes, and
doing so correctly via regression, has been raised previously.15–17
Therefore, a dual analysis approach has been proposed, first
assessing the treatment impact on the absolute phenotype and
then assessing the treatment impact on the phenotype relative to
body weight.18 This dual analysis strategy will give a more detailed
understanding of the impact of the treatment.
The International Mouse Phenotyping Consortium (IMPC19) aims
to phenotype knockouts for all protein coding genes in the mouse
genome, and provide the lines and data to form an open resource
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to the community. These high-throughput phenotyping pipelines
are designed to systematically test mice through a number
of assays in a standardised, unbiased manner to explore a range of
vertebrate biology. To provide a baseline for statistical analysis of
mutant phenotypes, the pipelines typically phenotype control
mice matched for age, sex and strain every week. Cumulatively, this
wild-type data set provides a substantial amount of information on
systematically phenotyped mice in numbers that are unusual in
hypothesis-driven mouse phenotyping. These data can provide
insights into physiology otherwise undetected under normal
laboratory conditions. The Wellcome Trust Sanger Institute Mouse
Genetics Project (MGP) has been running a high-throughput
phenotyping pipeline since 2006.20 The programme consists of
standardised and validated screens, but due to changing objectives,
the diet changed from a HFD to a breeders chow, giving large
quantities of B6N control data under the two conditions.
In this paper, we explore the B6N data sets of the MGP to
answer three questions. First, we capture the typical metabolic
profile for B6N mice under standard chow diet and HFD
conditions, using linear mixed model regression to fit an absolute
change model (ACM) to derive the absolute changes generated by
the HFD. Then, we fitted a weight-adjusted model (WAM) to assess
the influence of HFD on metabolic variables after adjusting for a
potential confounding effect of body weight. Then in both
models, we asked whether there are sexually dimorphic differ-
ences in the metabolic response to a HFD. As a resource to the
community, we provide the data and scripts.21
METHODS
Animals, housing and husbandry
B6N mice were phenotyped in weekly batches of seven males and females
as part of the standardised pipelines from the MGP at Wellcome Trust Sanger
Institute. Mice phenotyped by the Mouse GP pipeline (January 2011–
February 2012) were given a HFD from 4 weeks of age (Western RD, 829100,
21.4% crude fat content, 42% kcal as fat, ~ 0.2% cholesterol, Special Diet
Services, Witham, UK).20 Mice phenotyped by the MGP Select pipeline
(February 2012–February 2013) were given a breeders chow (Mouse Breeder
Diet 5021, 9% crude fat content, 21% kcal as fat, 0.276 p.p.m. cholesterol,
Labdiet, London, UK) from weaning. Diet compositions are given in Table 1.
All mice were given water and diet ad libitum, unless otherwise stated.
The care and use of mice in the Wellcome Trust Sanger Institute study
was carried out in accordance with UK Home Office regulations, UK
Animals (Scientific Procedures) Act of 1986 under two UK Home Office
licences that approved this work, which were reviewed regularly by the
Wellcome Trust Sanger Institute Animal Welfare and Ethical Review Body.
Phenotyping screen
Data from the following screens were included for analysis in this
manuscript: overnight fast followed by intraperitoneal glucose tolerance
test (ipGTT) at 13 weeks of age; dual-energy X-ray absorptiometry (DEXA)
at 14 weeks of age; and clinical chemistry at 16 weeks of age. The two
phenotyping pipelines were identical with the exception that the Mouse
GP has four additional screens (hair phenotyping, open field, hot plate and
stress-induced hypothermia tests). The analysis presented here assumes
that the omission of these screens in the MGP Select pipeline does not
impact the outcomes of the ipGTT, DEXA and clinical chemistry screens.
The final data set contained 296 female and 290 male mice from MGP
Select (breeders chow), and 363 female and 370 male mice from Mouse GP
(HFD). The experiment was not replicated, rather the analyses incorporates
data from a large time period encompassing many animals and litters.
DEXA was performed alongside the tests for auditory brainstem
response and whole body, high-resolution digital X-ray. Mice were
anaesthetised with ketamine hydrochloride. Nose to tail base length
measurements were performed using a ruler with 1 mm graduations prior
to DEXA measurement. Body composition parameters were measured
using a PIXImus densitometer in combination with Lunar PIXImus2 2.1
software (GE Lunar, Madison, WI, USA).
Intraperitoneal glucose tolerance test: mice were single housed and
fasted overnight (typically 16 h). A fasting (T0) blood sample from the tail
tip was directly taken (Accu-chek Aviva, Roche, Indianapolis, IN, USA). Mice
were then injected with 2 g kg− 1 glucose intraperitoneally. Further blood
samples were taken at 15 (T15), 30 (T30), 60 (T60) and 120 (T120) min post
glucose injection. Area under the curve was calculated using the trapezoid
method, where glucose at T0 was used as the baseline value for the
mouse. Glucose clearance rate in mM min− 1 was calculated by the formula
(glucose at T120–glucose at T30)/90.
Clinical chemistry: blood was collected from animals in the random-fed
state between 0830 and 1030. Mice were anesthetised using 100 mg kg− 1
Ketamine and 10 mg kg− 1 Xylazine, and blood was collected into
heparinised pediatric tubes (Kabe Labortechnik GmbH, Numbrecht,
Germany) using the retro-orbital route, followed by heart removal.
Heparinised whole-blood samples were centrifuged at 5000 r.c.f. for
10 min at 4 ⁰C, and the separated plasma analysed using an
Olympus AU400 (High Wycombe, UK).
Further information about housing and husbandry, experimental
procedures and pipeline quality control performed in the screen can be
found in the Supplementary Material.
Statistical and bioinformatics analysis
The individual mouse was considered the experimental unit within the
studies. An iterative top down mixed modelling strategy was performed as
described in Karp et al.22 using PhenStat version 2.3.2,23 an R package
freely available from Bioconductor.24 The package’s mixed model frame-
work was used inputting diet as the genotype variable. The ACM (Equation
1) was obtained by setting the argument equation to ‘withoutWeight’ and
the WAM (Equation 2) by setting the argument to ‘withWeight’.
Y Dietþ Sexþ Diet  Sexþ 19Batch  ð1Þ
Y Dietþ Sexþ Diet  SexþWeightþ 19Batch  ð2Þ
The reference group was the breeders chow (MGP Select) female mice, and
hence model estimates for ‘Sex’ are for the impact of being male and for
‘Diet’ the impact of the HFD. The covariance structure for the residual is
assessed, and if significant (Po0.05), then the model uses a hetero-
geneous model to account for the variance depending on diet. PhenStat
uses a model optimisation strategy, and therefore, if weight as a covariate
is not found to be a significant source of variation, it is dropped from the
modelling process, and in effect, the WAM is equivalent to the ACM. The
appropriateness of the models was assessed by visual inspection of
graphic tools provided with PhenStat. In Equation 2, where weight is
included as a covariate, the model adjusts for this variable by estimating
the linear relationship between the covariate and the variable of interest,
and as such makes two assumptions. First, that there is a linear relationship
between the confounding variable and the variable of interest, and
second, the assumption that a common linear relationship exists across
treatment groups (homogeneity of regression slope). These assumptions
can be assessed by plotting the confounding variable (body weight)
against the outcome (phenotypic measure) and comparing the gradients
on regression lines fitted for each experimental condition (pipeline). This
was inspected for each variable, and this assumption was found to not be
valid for five variables (log(alanine transaminase), log(aspartate amino-
transferase), alkaline phosphatase, low-density lipoprotein cholesterol and
free cholesterol). In these situations, the WAM was not appropriate. For
these variables, we explored the data and the relationship with weight
using a model that allowed for an interaction, and as the relationship was
complex and the effect of diet could not be separated from weight, no
weight-adjusted analysis was completed.
The appropriateness of the model output was also assessed by
inspection of normal quantile–quantile plots of the residuals, a box plot
Table 1. Diet composition of the breeders chow and the high-fat diet
Component Breeders chow
(% g g− 1) Mouse
Breeder Diet 5021
High-fat diet (% g g− 1)
Western RD, 829100
Crude protein 21.5 17.5
Crude fat 9 21.4
Cholesterol 2.76 × 10− 5 ~0.2
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that assessed the distribution of the residuals with batch by diet, and a plot
that compares the residuals against predicted for each diet. From this
analysis, four variables (insulin, creatine kinase, aspartate aminotransferase
and alanine transaminase) were found to have issues with the ‘normality of
residual’ assumption when fitted with Equation 1 and Equation 2. A log10
transformation addressed this issue.
Percentage change was calculated to allow comparison of the diet effect
for each sex across variables by taking the estimated coefficient from the
regression analysis and dividing it by the average signal seen for that
variable. Multiple testing was managed by controlling the family-wise error
rate to 5% using the Holm method.25
Data access and code availability
As a reference data set set for these animal models, we have made the
data freely available via Zenodo.21 As a reproducible analysis, we also
provide the scripts and output data that generated the results presented
within the manuscript.21
RESULTS
The effect of HFD, independent of sex and body weight
First, we investigated the impact of the HFD, assessing for
absolute changes in phenotypes independent of sex and body
weight differences by utilising the ACM (Table 2, Supplementary
Table 1). Body weight on average increased by 24% at the three
time points studied. For the other 38 variables examined, all were
statistical significantly different. With large group size of mice
contributing to the overall power to detect change of small effect
size, the effect size for a given parameter could be small. The
average largest effect seen across the two sexes for each variable
was 29% with a range of 1.5–135% (s.d.: 28.1%). If we arbitrarily
select a 5% threshold for biologically significance, then 87%
(33/38) of the variables were significantly affected by diet. As
expected for a HFD, glucose tolerance decreased, the body
composition was primarily affected by a substantial increase in fat
mass, and in plasma chemistry, most variables related to lipid and
protein metabolism were increased, however, plasma triglycer-
ides, creatinine and urea were decreased.
HFD affects phenotypes in a sexually dimorphic manner
Sex was found to be a statistically significant modifier of the effect
of diet for the majority of traits (78%, 32/41) (Figures 1 and 2;
Supplementary Table 1). By looking at the model estimates, the
change observed could be classified according to outcome.23 For
22% (9/41) of variables, the effect was equal across the two sexes.
For those classified as having a sexually dimorphic phenotype, the
effect was dominated by male-specific/more pronounced male
classifications (63.4%, 26/41) with the remainder being classified
as female-specific/more pronounced female (14.6%, 6/41)
(Figure 2). On average, for those variables classed as sexually
dimorphic, there was a 13.2% difference in the effect size between
the sexes (range: 0.42%–71.2%).
Glucose control, examined by ipGTT (Figure 1a), was affected in
a sexually dimorphic manner. Male mice on HFD showed
worsened blood glucose levels at almost all time points during
the ipGTT compared to the female HFD-fed mice. Also the glucose
clearance rate was only altered in the HFD males, while the HFD
female had a glucose clearance rate that was comparable to the
chow-fed females (Figure 1b). In terms of body composition, the
major effect of HFD was elevated fat mass (Figure 2a), although
sexually dimorphic effects were also noted for this and for bone
parameters, with males being more affected than females.
Regarding clinical chemistry, insulin levels were higher in male
HFD mice compared to female HFD mice (Figure 2b), as were liver
enzymes related to steatohepatitis, aspartate aminotransferase
and alanine transaminase. In addition, HFD males also had
worsened plasma lipid profiles, with higher cholesterol levels
compared to the HFD females (Figure 2c).
Inclusion of body weight as a covariate impacts the outcomes of
metabolic phenotype analysis
We then assessed the relationship between the variables and
body weight for the two diets. Visually, inspection of the
relationship between body weight and diet, found five variables
for which the relationship with weight depended on the diet (log
(aspartate aminotransferase), alkaline phosphatase, free choles-
terol, log(alanine transaminase) and low-density lipoprotein
cholesterol). These variables positively correlated with body
weight in HFD-fed mice, but not for the breeders chow-fed mice,
despite overlap in the body weight ranges for these diets
(Figure 3). This demonstrates selective, weight-independent
effects of HFD on important and commonly measured physiolo-
gical parameters. In addition, a positively correlated relationship
was seen between body weight and both lean mass and fat mass,
and the relationship was independent of diet (Supplementary
Figure 1). Therefore, for the five variables, the differing relationship
with weight is not due to an alternative relationship with lean or
fat mass (Supplementary Figure 2). Therefore, as the effect of body
size could not be separated from the effect of diet, these five
variables were not carried forward for further analysis.
For the remaining variables, we assessed the effect of diet on
the phenotype after adjusting for the confounding relationship
with weight using WAM. This determined the body-weight-
adjusted relative change in phenotype. With the model optimisa-
tion strategy implemented, weight as a covariate would only be
included if it was a significant source of variation (likelihood ratio
test Po0.05) and was included for 79% (26/33) of the variables.
Of the 33 variables assessed with the WAM model, the effect of
HFD was significant in 93.9% (31/33), and of those that were
significant, the average largest effect seen across the two sexes for
these variables was 18.2% (range: 1.9–58.9%, s.d.: 15.7%).
Including an additional arbitrary biological filter of 5% leads to
Table 2. Summary of the impact of the HFD on B6N mice as an
absolute change in phenotype after controlling the family-wise error
rate to 5% using data collected from the WTSI high-throughput
phenotyping pipeline
Screen Increased variables Decreased variables





ipGTT area under curve
DEXA Fat mass Lean mass
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Bone mineral content
Bone mineral density


















Abbreviations: DEXA, dual-energy X-ray absorptiometry; HFD, high-fat diet;
ipGTT, intraperitoneal glucose tolerance test; WTSI, Wellcome Trust Sanger
Institute.
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72.7% (24/33) of variables being classed as significantly different
between the breeder’s chow diet and HFD. In addition, of those
classed as statistically significant, sex was found to be a modifier
of the effect of diet for the majority of traits (81.8%, 27/33)
(Figure 4). For just 12% (4/33), the effect was classed as ‘both sexes
equally’ as there was no evidence of an interaction between sex
Figure 1. The estimated effect of a HFD on glucose tolerance for B6N mice. Glucose tolerance measures on B6N mice collected from an ipGTT
screen implemented at the high-throughput phenotyping project at the WTSI. HFD data: 296 female and 290 male mice; Breeder’s chow: 363
female and 370 male mice. (a) The blood glucose levels as a function of time during the ipGTT screen. The error bars indicate s.d. (b) The
estimated effect of the HFD for each sex (blue for male and red for female) and for each variable associated with ipGTT screen with 95%
confidence intervals from fitting an ACM. The star indicates statistical significance for the variables in a sex-independent manner and SD
indicates the phenotype was classed as sexually dimorphic. CI, confidence interval; SD, sexually dimorphic; WTSI, Wellcome Trust Sanger Institute.
Figure 2. The estimated effect of the HFD from fitting an absolute change model and the role of sex in modifying the effect. Body
composition and clinical chemistry measures on B6N mice collected from the high-throughput phenotyping project at the WTSI. Shown
are outputs from fitted an absolute change model. HFD data: 296 female and 290 male mice; Breeder’s chow: 363 female and 370 male mice.
(a–d) The estimated effect of the HFD for each sex (blue for male and red for female) and for each variable. The error bars indicate the 95%
confidence interval. The star indicates statistical significance and SD indicates the phenotype was classed as sexual dimorphic. (a) Body
composition variables. (b) Proteins and enzyme variables. (c) Lipid variables. (d) Mineral variables. (e) The classification of how sex modified
the effect of diet across all variables fitted with the absolute change model. SD, sexually dimorphic; WTSI, Wellcome Trust Sanger Institute.
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and diet, while for those identified as having a sexually dimorphic
phenotype, the effect was dominated by male-specific/male
stronger classifications (48.4%, 16/33) compared to female-
specific/female stronger (30.3%, 10/33). One variable, DEXA bone
area, was found to be sexually dimorphic, but with the direction of
effect in opposite directions for each sex (Figure 4). On average,
for those classed as sexually dimorphic, there was a 9.5%
difference in the effect between the sexes (range: 0.42–29.4%).
Our analysis demonstrates that after accounting for body
weight differences, the majority of variables were still significantly
different between the breeder’s chow diet and HFD. However, the
average maximum effect size across the sexes was reduced (ACM:
29%, WAM: 18.2%). In addition, for sexually dimorphic variables,
the inclusion of body weight as a covariate reduced the size of the
difference seen between the sexes (ACM: 13.2%, WAM: 9.5).
DISCUSSION
We have used data generated from our high-throughput
phenotyping pipeline to develop a core resource for research
centred on the B6N mouse. In total, we use data on 41 metabolic-
related variables from 1319 mice to produce a highly sensitive
assessment of the impact of diet and sex on these variables. This
extensive reference data set finds that the HFD has a wide-ranging
impact on the metabolic variables, both when assessed for an
absolute phenotypic difference and in the relative phenotypic
effect where body weight is accounted for. While a number of
papers have previously considered the metabolic profile of B6N
mice,1,26,27 to date, little attention has considered the role of sex in
the phenotype, particularly in conjunction with HFD.
Our analysis finds that sex is a significant modifier of the impact of
HFD (78% of variables with the ACM) and is dominated by the males
being affected to a greater degree than the females. The finding
that sex is a significant modifier, supports the call4,5,10,28 to always
consider sex when designing and analysing in vivo studies. Indeed,
sexual dimorphism in metabolic disorders such as obesity29 and
atherosclerosis30 are well described and biologically important
element of understanding their aetiologies. However, most in vivo
studies focus on male mice.4 Historically, females were thought to
have greater variability due to the oestrogen cycle, this however has
been largely disproven.31,32 In addition, previous studies have noted
that the development of obesity and hyperglycaemia is strain-
dependent and dependent on sex.33,34 The extent of sexual
dimorphism seen in this data set, combined with previous examples
of phenotypic outcomes depending on sex, demonstrate the
importance of assessing the role of sex when conducting research
to understand disease progression, severity and treatment.
In general, many of the global findings on weight and glucose
control for the effect of HFD on C57BL/6N observed were similar
to those previously published.35–37 Our comprehensive analysis
also identifies additional variables that are affected by HFD in the
C57BL/6N background. The challenge with using mouse models
for complex diseases, such as obesity and the metabolic
syndrome, is that certain phenotypic outcomes may not fully
recapitulate all aspects of the human disease. For example, we
find that plasma iron levels are reduced in C57BL/6N HFD-fed
mice, which matches the general observation that obesity
corresponds with iron deficiency in humans.38 However, markers
of elevated iron stores such as hyperferritinemia occur in a subset
of metabolic syndrome patients and has been termed ‘dysmeta-
bolic iron overload syndrome’.39 Similarly, bilirubin levels are
inversely correlated with prevalence of type 2 diabetes in
humans,40 and mouse models of insulin resistance are protected
by haem oxygenase-induced production of bilirubin.41 However,
increased haem oxygenase-1 expression is associated with insulin
resistance and loss of haem oxygenase-1 also appears to be
protective against metabolic disorders in mouse.42 In our analysis,
bilirubin levels are elevated in HFD-fed mice, suggesting that the
haem oxygenase-bilirubin pathway may be enhanced, thereby
altering the baseline that the effect of interventions must be
measured from. Our data therefore suggest that the design and
interpretation of studies using HFD-fed mice to model human
diseases should be careful evaluated.
In addition to the high prevalence of sexual dimorphism, our
analysis found that with diet impacted most variables both when
assessing the phenotypic change in absolute and relative terms.
The use of a body weight correction by regression has been
proposed for certain metabolic assays, for example, indirect
calorimetry measurements of energy expenditure15 or body
composition measures.43 A dual analysis, assessing both absolute
and relative phenotypic changes, gives a richer understanding of
the treatment. Bone mineral density (BMD), is one variable where
published analysis has frequently considered the animal size as a
co-variable. In humans, obesity is thought to increase BMD by
mechanical loading, but also increases fracture risk.44 However,
other studies point to an inverse relationship with BMD.45,46 These
conflicting observations highlight the complexity of the relation-
ship, an observation that is also seen in the mouse literature. For
example Li et al.,47 studying multiple inbred mouse strains,
concluded that the relationship between BMD and body
composition, particularly fat mass, is dependent on the diet used.
They also reported that while sex had no net effect on BMD, once
body weight is taken into account, females have a higher BMD
than males. In comparison, using the ACM on our B6N mouse
data, we find that HFD affects bone density in a sexually
Figure 3. Example relationship between body weight and pheno-
typic trait of interest. The relationship between body weight and
selected phenotypes observed for B6N mice from the high-
throughput phenotyping project at the WTSI. HFD data: 296 female
and 290 male mice; Breeder’s chow: 363 female and 370 male mice.
Shown in red are female mice and blue are male mice. Closed circles
represent HFD-fed mice and open circles chow-fed animals. The
fitted line is a regression line. (a) Amylase; (b) LDL cholesterol. LDL,
low-density lipoprotein. WTSI, Wellcome Trust Sanger Institute.
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dimorphic manner, so that males have a greater response than
females. In comparison, using the WAM to take body weight into
account, we find the relative effect of HFD is an unchanged BMD
in males but lowered BMD in females. As noted by Li et al. and
others,47–49 the relationships between body composition, BMD,
genetics, diet and environment are complex, and the experi-
mental design, the model system and the specific variables and
co-variables measured will play a significant part in the outcome
from dietary interventions.
In summary, we have produced a reference data set for
normal and HFD-fed C57BL6/N mice from a standardised
phenotyping pipeline. We demonstrated that sexual dimorphism
exists in the response to the diet in a large range of common
metabolic variables, and suggest that analysis examining the
effect of sex and body weight on phenotypes should be
encouraged.
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